Patent Document ID: 20160122822
Application ID: 14897670
Patent Flag: 0

Claim One:
1. A method comprising determining the susceptibility of a first dog to hip dysplasia based upon the presence or absence of one or more mutations in one or more genes selected from the group consisting of: Gene Location Laminin alpha 2 Chromosome 1: 70,790,697-71,150,490 subunit Fragment LSM4 homolog, U6 small Chromosome 20: 47,714,464-47,721,805 nuclear RNA associated Collagen, type VI, alpha 3 Chromosome 25: 50,995,186-51,063,665 CDP-diacylglycerol Chromosome 32: 11,331,461-11,375,767 synthase (phosphatidate cytidylyltransferase) 1 inositol polyphosphate- Chromosome 25: 47,629,437-47,731,096 5-phosphatase SH3-domain binding protein 4 Chromosome 25: 49,142,306-49,155,351 histone deacetylase 4 Chromosome 25: 52,342,017-52,443,682 Leucine rich repeat protein 1 Chromosome 8: 29,236,409-29,246,995 v-ski sarcoma viral Chromosome 5: 60,146,103-60,213,750 oncogene homolog prostaglandin D2 Chromosome 8: 31,485,692-31,494,066 In the genome of the first dog.